Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Classical hematology 1

Conditions

Interventions

Paclitaxel 337 pembrolizumab 333 Carboplatin 330 Cisplatin 277 Gemcitabine 264 Docetaxel 251 Bevacizumab 240 Nivolumab 230 Pemetrexed 211 Rituximab 183 Dexamethasone 183 Cyclophosphamide 170 Capecitabine 169 Trastuzumab 149 Fluorouracil 147 Ipilimumab 121 atezolizumab 119 Prednisone 118 Erlotinib Hydrochloride 116 Oxaliplatin 109 Cetuximab 104 Sunitinib 101 Doxorubicin 98 Leucovorin 97 Lenalidomide 93 Irinotecan 89 130-nm albumin-bound paclitaxel 84 durvalumab 78 Bortezomib 77 Azacitidine 73

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Has results × Factor VIII × Clear all

NCT02847637 2022-11-16

HAVEN 3

Hoffmann-La Roche

Phase 3 Completed

152 enrolled 46 charts 1 FDA

Classical hematology

Hemophilia A

Data powered by HemOnc (CC BY 4.0) Colophon ⚡